Abstract:Objectives: A Patterns of Care Study (PCS) was performed in the largest regional medical center in Zhejiang Province, China. The hospital information system (HIS) was used to evaluate patient characteristics and changes in initial treatment patterns for prostate cancer and to determine recent predominant trends in treatment plans for prostate cancer (PCa) in China. Methods: Men who were newly diagnosed with localized or locally advanced PCa for 2010-2011 and 2016-2017 were identified in the HIS database. Patient characteristics and temporal trends in initial management were assessed, and differences between groups were evaluated for significance using Chi-square and Mann-Whitney U tests. Results: In total, 1792 patients met the study criteria, including 505 and 1287 patients in the 2010-2011 and 2016-2017 samples, respectively. The average age of patients diagnosed in the 2010-2011 PCS survey was 70 years, decreasing to 68 years when the 2016-2017 patients were included (P<0.001). In the 2010-2011 sample, 50.69% of the patients had an initial prostate-specific antigen (PSA) level ≥20 ng/ml. In contrast, the initial PSA level was 4-19.99 ng/ml for 66.67% of the patients in the 2016-2017 sample (P<0.001). Based on National Comprehensive Cancer Network (NCCN) criteria, the percentages of patients in low- and intermediate-risk groups increased from 33.06% to 54.78%; conversely, the percentages in high-risk, very high-risk, and regional (N1) groups decreased to a certain extent (P<0.001). According to European Association of Urology (EAU) criteria, the percentages of patients in low- and intermediate-risk groups increased from 32.07% to 53.69%, yet the percentage in the high-risk group decreased (P<0.001). The use of radical prostatectomy (RP) and radiation therapy (RT) increased from 48.32% to 76.46% and 5.35% to 16.94%, particularly in high-risk and low-risk groups, respectively, whereas the rates of hormone therapy (HT) and active surveillance and observation (AS&O) decreased from 32.28% to 4.27% and from 16.04% to 2.33%, respectively (P<0.001). A similar pattern was observed when patients were stratified by EAU risk group. Conclusions: The results of this real-world study in the largest regional medical center in Zhejiang Province, China, indicate that the predominant characteristics of PCa patients and trends in initial management are changing rapidly. We found the following: (a) a trend toward a decreased age among newly diagnosed patients; (b) a trend toward lower initial PSA levels; (c) a downward trend in risk group classification; (d) a significant increase in the likelihood of receiving RP, particularly in the high-risk group; (e) an increase in the rate of RP, mostly due to use of the Da Vinci robotic system; (f) a significant increase in the likelihood of receiving RT, especially in the low-risk group; and (g) a decrease in HT and AS&O.

How to practice clinical evidence-based medicine?——Perplexity and challenge in diagnosis and treatment of prostate cancer

Comparison of the clinicopathologic features of prostate cancer in US and Chinese populations

Keeping integrity and innovation, striving for the future: retrospect and prospect of diagnosis and treatment of prostate cancer in China

Hot Issues on Chinese Expert Consensus of Prostate Cancer Management

Trends in Treatment for Prostate Cancer in China: Preliminary Patterns of Care Study in a Single Institution

Recent Advances in Imaging-Guided Interventions for Prostate Cancers.

Guidelines for the Diagnosis and Treatment of Pancreatic Cancer in China (2021)

[Using the Theory of Precision Medicine to Optimize the Multidisciplinary Comprehensive Treatment of Prostate Cancer].

Prostate Cancer in Asia: A Collaborative Report

Current status of prostate biopsy in Chinese Prostate Cancer Consortium member hospitals

Advances in basic research, clinical diagnosis and treatment of prostate cancer in 2022

ocal Syndrome Differentiation in Diagnosis and Treatment of Chronic Prostatitis

Controversies on individualized prostate cancer care: gaps in current practice

Early Diagnosis of Prostate Cancer from the Perspective of Chinese Physicians.

Epidemiology of prostate cancer in China: an overview and clinical implication

Diagnosis and treatment of malignant tumors using integrated traditional and western medicine: Progress, challenges and reflections

Prostate cancer in East Asia: evolving trend over the last decade.

Where are the future directions in prostate cancer diagnosis and treatment in Asia

Present Situation for Diagnosis and Treatment of Carcinoma of Prostate: A Report of 263 Cases

CACA guidelines for holistic integrative management of prostate cancer

Intelligent medicine in focus: the 5 stages of evolution in robot-assisted surgery for prostate cancer in the past 20 years and future implications